Search

everythinglearnresearchcommunity

for

Search:↓

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Drug repurposing shows promise for treating many medical conditions.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

EGF controls hair growth by regulating hair follicles' growth phases.

SOX4 is crucial for the development of melanoma.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

A girl with lupus had unusually long and thick eyelashes, a rare symptom of her condition.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Lasers can help reduce skin side effects from cancer treatment.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Collagen XVII is crucial for skin cell growth and nail health.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Skin's epithelial stem cells are crucial for repair and maintenance, and understanding them could improve treatments for skin problems.

Afatinib often causes skin problems that need proactive management.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

The symposium concluded that environmental factors significantly contribute to skin aging.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.